Following initial public offering filings from BP and Oasis, The Deal has learned of at least two more planned debuts this year. Meanwhile, a number of midstream and upstream transactions took place over the past week.
The Street's sister publication, The Deal, looked back over proxy season 2017 to pinpoint the more noteworthy trends and see what might be in store for next year.
Large pharmaceutical companies could be interested in buying the drug company, but even if a deal isn't forthcoming an activist investor could seek to elect directors and make one happen
The deal, worth up to $206.5 million, comes when the entertainment company expands into live entertainment as its sports teams, led by the New York Knicks, have struggled.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.